Reuters: J&J chief gets president's ear on job growth

Johnson & Johnson ($JNJ) CEO Bill Weldon (photo) is among the corporate executives set to meet with President Obama Friday afternoon to talk about economic woes and prospects for job creation, sources tell Reuters. Report

Suggested Articles

Pfizer will exit its Perth, Australia sterile injectables manufacturing site by 2024 as part of a global production reorganization effort.

Agios has withdrawn a European application for Tibsovo in AML after the same phase 1 data that earned it an FDA nod failed to impress the EMA.

Sanofi is reportedly considering a sale of some of its anti-inflammation drugs that could snare $234 million as the company pivots toward Dupixent.